MIRA INFORM REPORT

 

 

Report Date :

23.08.2013

 

IDENTIFICATION DETAILS

 

Name :

LONZA INDIA PRIVATE LIMITED [w.e.f.30.04.2007]

 

 

Formerly Known As :

CAMBREX INDIA PRIVATE LIMITED [w.e.f.10.10.2003]

 

CAMBREX CHEMICALS PRIVATE LIMITED

 

 

Registered Office :

Corpora, 2nd Floor, LBS Marg, Bhandup (West), Mumbai - 400078, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

25.01.1999

 

 

Com. Reg. No.:

11-117983

 

 

Capital Investment / Paid-up Capital :

Rs. 23.459 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH1999PTC117983

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader, Distributor and Exporter of Active Pharmaceutical Ingredients and also Providing Marketing, Business Support, Contract Research and Development Services.

 

 

No. of Employees :

30 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (53)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 1539000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a good track record.

 

The financial position of the company is good.

 

Trade relations are reported as fair. Business is active. Payment terms are regular and as per commitments.

 

The company can be considered for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY [GENERAL DETAILS]

 

Name :

Ms. Minal

Designation :

Accounts Department

Contact No.:

91-22-43424026

Date :

23.08.2013

 

 

LOCATIONS

 

Registered Office :

Corpora, 2nd Floor, LBS Marg, Bhandup (West), Mumbai - 400078, Maharashtra, India

Tel. No.:

91-22-43424000/ 43424026

Fax No.:

91-22-43424050

E-Mail :

vivek.save@lonza.com

contact.india@lonza.com

Website :

http://www.lonza.com

Location :

Owned

 

 

DIRECTORS

 

AS ON 24.09.2012

 

Name :

Mr. Vivek Vasant Save

Designation :

Managing director

Address :

Flat No. 301, Aarthi Aakash Deep, Lane No. 1, Indian Airlines Employees Housing Colony, Begumpet, Secunderabad – 500003, Andhra Pradesh, India

Date of Birth/Age :

30.06.1959

Date of Appointment :

02.02.2012

DIN No.:

05191822

 

 

Name :

Mr. Lukas Utiger

Designation :

Director

Address :

6922 Sarazen DR Middletown F MD Maryland – 21769 United States of America

Date of Birth/Age :

14.01.1963

Date of Appointment :

18.01.2011

DIN No.:

03414137

 

 

KEY EXECUTIVES

 

Name :

Ms. Minal

Designation :

Accounts Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 24.09.2012

 

Names of Shareholders

 

No. of Shares

 

Vijay Kumar Belavadi

 

3

Lonza Bioproducts AG

 

2345852

Subramayan Umakanth

 

3

 

 

 

Total

 

2345858

 

 

AS ON 24.09.2012

 

Equity Share Breakup

Percentage of Holding

Category

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader, Distributor and Exporter of Active Pharmaceutical Ingredients and also Providing Marketing, Business Support, Contract Research and Development Services.

 

 

Exports :

 

Products :

Finished Goods

 Countries :

·         Middle East Countries

 

 

Terms :

 

Selling :

L/C and Credit

 

 

Purchasing :

L/C and Credit

 

 

GENERAL INFORMATION

 

Customers :

End Users

 

 

No. of Employees :

30 (Approximately)

 

 

Bankers :

·         Yes Bank

·         HSBC Bank

 

 

Facilities :

 

Secured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Term loans

 

 

From bank*

1.983

0.000

SHORT TERM BORROWINGS

 

 

Loans repayable on demand

 

 

Overdraft facility from

 

 

Yes bank**

0.039

0.000

Total

2.022

0.000

 

Notes:

 

LONG-TERM BORROWINGS

 

* The term loan from bank is a vehicle loan from HDFC Bank Ltd. taken in the current financial year which carries interest at the rate Of 11.33%. It is repayable in 60 equal monthly installments of Rs. 0.026 Million each commencing from 10 March, 2012. The term loan is secured by hypothecation of vehicles obtained using the term loan.

 

** The Company had availed External Commercial Borrowings (ECB) from its holding company viz. Lonza Bioproducts AO, Switzerland In the year 2011 and 2012 amounting to $ 3,000,000 and $ 2,000,000 respectively. The yearend balance of the ECB as at 31 March 2012 is $ 5.000,000. The interest is based on 6 month LIBOR rate plus a margin of 300 basis points. The loan is repayable In 10 equal installments commencing from October 2012

 

SHORT TERM BORROWINGS

 

* Overdraft from HSBC bank carries interest at HSBC bank base rate (ranges from 8% to 10%) payable on a monthly basis on the actual amount utilised. As per the terms of sanction letter, the Company Is submitted letter of comfort from Lonza Croup Limited

 

** Overdraft from Yes bank carries Interest at the rate of 11 % payable on a monthly basis on the actual amount utilised. The overdraft facility is secured by fixed deposits of the Company.

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

BSRR and Company

Chartered Accountants

Address :

Reliance Humsafar, 4th Floor, Road No.11, Banjara  Hills, Hyderabad – 500034, Andhra Pradesh, India

Income-tax PAN of auditor or auditor's firm :

AAKFB1884H

 

 

Holding Company :

Lonza Bioproducts AG

 

 

Subsidiary Company :

Lonza Infrastructure Private Limited [U45202MH2010PTC202179]

 

 

Entities under common control with whom there were transactions during the year :

·         Lonza AO

·         Lonza Biologies Plc. UK.

·         Lonxa Biologies Tuas Pte Limited

·         Lonza Bioscience Singapore Pte Limited

·         Lonza Cologne GMBH

·         Lonza Inc (Allendale)

·         Lonza Nanjing Limited

·         Lonza Rockland Inc.

·         Lonza Sales Limited

·         Lonza Verviers SPRL

·         Lonza Waikersville Inc. USA

·         Lonza Guangzhou Limited

·         Lonza Japan Limited

·         Lonza Microbial Control Asia Pte. Limited

·         Lonza Infrastructure India Private Limited

·         Lonza Bioscience Singapore Pte. Limited

·         Lonza (China) Investment Company Limited

·         Lonza Biotech

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5,000,000

Equity Shares

Rs. 10/- each

Rs. 50.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

2,345,858

Equity Shares

Rs. 10/- each

Rs. 23.459 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

23.459

23.459

(b) Reserves & Surplus

 

361.373

310.060

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

384.832

333.519

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

231.908

133.950

(b) Deferred tax liabilities (Net)

 

0.000

0.007

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.482

0.427

Total Non-current Liabilities (3)

 

232.390

134.384

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

28.955

0.000

(b) Trade payables

 

88.519

53.852

(c) Other current liabilities

 

58.444

21.174

(d) Short-term provisions

 

14.730

5.734

Total Current Liabilities (4)

 

190.648

80.760

 

 

 

 

TOTAL

 

807.870

548.663

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

86.132

72.902

(ii) Intangible Assets

 

0.168

0.422

(iii) Capital work-in-progress

 

196.243

29.937

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.100

0.100

(c) Deferred tax assets (net)

 

7.563

0.000

(d)  Long-term Loan and Advances

 

31.645

32.897

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

321.851

136.258

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

38.629

35.924

(c) Trade receivables

 

106.469

47.138

(d) Cash and cash equivalents

 

330.601

323.777

(e) Short-term loans and advances

 

5.139

4.933

(f) Other current assets

 

5.181

0.633

Total Current Assets

 

486.019

412.405

 

 

 

 

TOTAL

 

807.870

548.663

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

12.747

2] Share Application Money

 

 

35.487

3] Reserves & Surplus

 

 

107.893

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

156.127

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

0.000

DEFERRED TAX LIABILITIES

 

 

0.008

 

 

 

 

TOTAL

 

 

156.135

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

30.641

Capital work-in-progress

 

 

1.287

 

 

 

 

INVESTMENT

 

 

0.000

DEFERRED TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

18.949

 

Sundry Debtors

 

 

43.419

 

Cash & Bank Balances

 

 

72.151

 

Other Current Assets

 

 

0.000

 

Loans & Advances

 

 

24.001

Total Current Assets

 

 

158.520

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

31.448

 

Other Current Liabilities

 

 

2.865

 

Provisions

 

 

0.000

Total Current Liabilities

 

 

34.313

Net Current Assets

 

 

124.207

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

156.135

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

 

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Revenue from operations

524.818

387.851

158.345

 

 

Other Income

35.346

10.186

81.321

 

 

TOTAL                                    

560.164

398.037

239.666

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

482.193

346.591

191.311

 

 

 

 

 

 

PROFIT BEFORE TAX

77.971

51.446

48.355

 

 

 

 

 

Less

TAX                                                     

26.658

17.304

17.390

 

 

 

 

 

 

PROFIT AFTER TAX

51.313

34.142

30.965

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

142.035

107.893

76.928

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

193.348

142.035

107.893

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Sale of Products

170.150

98.769

70.120

 

 

Sale of Services

59.895

52.614

1.057

 

TOTAL EARNINGS

230.045

151.383

71.177

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Traded Goods

94.916

137.002

8.920

 

 

Capital Goods

12.857

32.735

69.903

 

TOTAL IMPORTS

107.773

169.737

78.823

 

 

 

 

 

 

Earnings Per Share (Rs.)

21.87

14.55

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

9.16

8.58

12.92

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

14.86

13.26

30.54

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

12.91

9.92

25.56

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.20

0.15

0.31

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.68

0.40

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.55

5.11

4.62

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

No

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOANS

 

Unsecured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

From Lonza Bioproducts AO, holding company**

229.925

133.950

SHORT TERM BORROWINGS

 

 

Loans repayable on demand

 

 

Overdraft facility from

 

 

HSBC bank*

28.916

0.000

Total

258.841

133.950

 

 

Note:

The registered office of the company has been shifted from 652, Solitaire Corporate Park, Chakala, Andheri (East), Mumbai – 400093, Maharashtra, India to the present w.e.f.01.12.2008

 

 

OVERVIEW

 

Subject is a wholly owned subsidiary of Lonza Bioproduets AG, Switzerland. The Company was formed by acquiring Cambrex India Private Limited and the name of the Company was changed to Lonza India Private Limited on 30 April 2007. The Company is engaged in trading of active pharmaceutical ingredients and providing marketing, business support, contract research and development services.

 

 

OPERATIONS:

 

During the year, the revenue from operation of the Company was Rs.524.818 Millions as compared to revenue from operation of Rs387.851 Millions during the previous year, registering growth of 35.31%. The profit after tax has increased by 50.29% to Rs.51.313 Millions compared to profit after tax of Rs 34.141 Millions in previous year

 

The Company's project in SEZ at Shameerpet. Hyderabad is in progress

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.03.2012

31.03.2011

 

 

(Rs. in Millions)

Income-tax demand* for AY 2008-09

0.000

0.001

Income-tax demands (including TDS) AY 2009-10

0.000

0.205

Income-tax demands (inclusive of interest) in respect of fringe benefit tax for AY 2009-10

0.000

0.460


FIXED ASSETS:

 

·         Leasehold Land

·         Freehold Land

·         Plant and machinery

·         Office Equipments

·         Computers

·         Furniture and Fixture

·         Vehicles

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 65.42

UK Pound

1

Rs. 102.10

Euro

1

Rs. 87.32

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

6

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

53

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.